Primary Panel, MGIT Susceptibility
Laboratory Fee Schedule
Procedure #: PZM0001A
CPT: 87188 x 4
Synonym(s): | M. tuberculosis complex primary drug panel, MTB, MGIT DST, susceptibility testing |
---|---|
Requisition Form | G-MYCO |
Test Description | MGIT drug susceptibility test to Isoniazid @ 0.4 µg/mL, Isoniazid @ 0.1 µg/mL, Ethambutol and Rifampin |
Pre-Approval Needed | N/A |
Supplemental Information Required | N/A |
Supplemental Form(s) | N/A |
Performed on Specimens from (sources) | Pure isolate from human sources. |
Sample/Specimen Type for Testing | M. tuberculosis complex pure isolate in liquid or on solid culture medium |
Minimum Volume/Size Required |
|
Storage/Preservation Prior to Shipping | Ambient |
Transport Medium | N/A |
Specimen Labeling |
|
Shipping and Specimen Handling Requirements |
|
Method | MGIT drug susceptibility tests interpreted as either susceptible or resistant to a specific drug at critical concentration recommended by CLSI. |
Turn-around Time | 14 days. |
Interferences/Limitations | Test can only be performed on pure cultures of M. tuberculosis complex. |
Common Causes for Rejection |
|
Additional Information |
|